121 results on '"Sowers, James R"'
Search Results
2. Inhibition of sphingomyelinase attenuates diet – Induced increases in aortic stiffness
3. Endothelial sodium channel activation mediates DOCA-salt-induced endothelial cell and arterial stiffening
4. FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis
5. Insulin resistance, cardiovascular stiffening and cardiovascular disease
6. Commentary: COVID-19 and obesity pandemics converge into a syndemic requiring urgent and multidisciplinary action
7. Targeting endothelial exosomes for the prevention of cardiovascular disease
8. Endothelial sodium channel activation promotes cardiac stiffness and diastolic dysfunction in Western diet fed female mice
9. Commentary: COVID-19 in patients with diabetes
10. Epithelial sodium channels in endothelial cells mediate diet-induced endothelium stiffness and impaired vascular relaxation in obese female mice
11. Endothelial cell senescence in aging-related vascular dysfunction
12. Corrigendum to “FUNDC1 insufficiency sensitizes high fat diet intake-induced cardiac remodeling and contractile anomaly through ACSL4-mediated ferroptosis” [Metabolism 122 (September 2021) 154840]
13. Metabolic Stress, Autophagy, and Cardiovascular Aging: from Pathophysiology to Therapeutics
14. Depletion of dendritic cells in perivascular adipose tissue improves arterial relaxation responses in type 2 diabetic mice
15. Enhanced endothelium epithelial sodium channel signaling prompts left ventricular diastolic dysfunction in obese female mice
16. Uric acid promotes vascular stiffness, maladaptive inflammatory responses and proteinuria in western diet fed mice
17. Daily exercise prevents diastolic dysfunction and oxidative stress in a female mouse model of western diet induced obesity by maintaining cardiac heme oxygenase-1 levels
18. The Renin Angiotensin Aldosterone System in Obesity and Hypertension: Roles in the Cardiorenal Metabolic Syndrome
19. Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial
20. Basic science: Pathophysiology: the CardioRenal Metabolic Syndrome
21. Dipeptidyl peptidase inhibition prevents diastolic dysfunction and reduces myocardial fibrosis in a Mouse model of Western diet induced obesity
22. Thyroid and the Heart
23. Renin Inhibition and AT1R blockade improve metabolic signaling, oxidant stress and myocardial tissue remodeling
24. Therapy of obese patients with cardiovascular disease
25. Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
26. Insulin Resistance and Heart Failure: Molecular Mechanisms
27. Over-nutrition and metabolic cardiomyopathy
28. Nebivolol improves insulin sensitivity in the TGR(Ren2)27 rat
29. Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups
30. Hypertension in Obesity
31. Treatment of hypertension in patients with diabetes—an update
32. Obesity is associated with increased parathyroid hormone levels independent of glomerular filtration rate in chronic kidney disease
33. Insulin- and Aldosterone-Mediated Signaling in Endothelial Cells Converge on SGK1 to Promote Endothelial Sodium Channel Activation
34. Chapter 5 - Mechanisms underlying vascular stiffening in obesity, insulin resistance, and type 2 diabetes
35. Treatment of hypertension in patients with diabetes—an update
36. Renin-angiotensin-aldosterone system-mediated redox effects in chronic kidney disease
37. Diabetes Mellitus and CKD Awareness: The Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES)
38. The Renin Angiotensin Aldosterone System in Hypertension: Roles of Insulin Resistance and Oxidative Stress
39. Endocrine Functions of Adipose Tissue: Focus on Adiponectin
40. Treating hypertension while protecting the vulnerable islet in the cardiometabolic syndrome
41. Prevalence and Associations of Anemia of CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004
42. CKD in the United States: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004
43. Diabetes Mellitus in CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition and Examination Survey (NHANES) 1999-2004
44. Exercise training prevents development of cardiac contractile dysfunction in hypertensive TG(mREN2)27 rats
45. Understanding essential hypertension from the perspective of the cardiometabolic syndrome
46. Diabetic Hypertension
47. Chapter 2 - Estrogen Receptor Signaling and Cardiovascular Function
48. High-fat meal impairs vascular compliance in a subgroup of young healthy subjects
49. Insights into the biology of diabetic vascular disease: What’s new?
50. Insulin and insulin resistance:: impact on blood pressure and cardiovascular disease
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.